Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03498170 · ClinicalTrials.gov registry record · Phase 1
The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants
A Phase 1 study of Interaction, sponsored by Mereo BioPharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT03498170 is a Phase 1 study of Interaction that has completed, run by Mereo BioPharma. The registered enrollment target is 16 participants, below the 23-participant average among 3 other Interaction trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03498170, a Phase 1 study of Interaction, has completed, sponsored by Mereo BioPharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
An Open-label, 2-period, Single-sequence, Crossover Study to Evaluate the Effect of Multiple Oral Dosing of Itraconazole on BCT197 Systemic Exposure in Healthy Male Participants.
Conditions Studied
Interventions
- DRUG Itraconazole 200 mg
- DRUG BCT197
Study Locations (1)
Florida
- inVentiv Health Clinical Research Services LLC - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-03-19 |
| Est. Completion | 2018-05-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03498170
The ClinicalTrials.gov registry entry for NCT03498170 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 23-participant average among 3 other Interaction trials with a reported enrollment target (30% lower). The listed sponsor is Mereo BioPharma, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Interaction appearing as the primary indexed condition, and to 2 interventions - of which Itraconazole 200 mg is the first listed.
NCT03498170 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03498170 about?
NCT03498170 is a clinical study titled "The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants". An Open-label, 2-period, Single-sequence, Crossover Study to Evaluate the Effect of Multiple Oral Dosing of Itraconazole on BCT197 Systemic Exposure in Healthy Male Participants.
What is the current status of trial NCT03498170?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2018-03-19. Estimated completion is 2018-05-09.
What conditions does trial NCT03498170 study?
This clinical trial studies the following conditions: Interaction.
What interventions are being tested in trial NCT03498170?
The interventions under investigation include: Itraconazole 200 mg (DRUG), BCT197 (DRUG).
Who is sponsoring clinical trial NCT03498170?
This trial is sponsored by Mereo BioPharma, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03498170 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interaction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
RECRUITING · Early Phase 1
-
Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
RECRUITING · Early Phase 1
-
Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.